Press Releases
Jeremy Lenz, BBAM VP of Operations, to serve on University Enterprise Laboratories’ Board of Directors
ST. LOUIS PARK, Minn. (July 8, 2010)- Jeremy Lenz, BioBusiness Alliance of Minnesota (BBAM) Vice President of Operations, is joining the University Enterprise Laboratories Inc. (UEL) Board of Directors.
BioBusiness Alliance, Canadian Light Source Synchrotron Agreement Lights Way to New Life Science Research Partnerships
ST. LOUIS PARK, Minn. (May 19, 2010) - Bringing the power of synchrotron light to Minnesota’s academic and industrial life science researchers is the aim of a Memorandum of Agreement (MOA) signed today between the BioBusiness Alliance of Minnesota (BBAM) and Canada’s national synchrotron facility, the Canadian Light Source (CLS).
BioBusiness Alliance provides greater access to online resources
ST. LOUIS PARK, Minn. (April 27, 2010) – The BioBusiness Alliance of Minnesota (BBAM) unveils its new web site and upgraded BIOMAP interactive tool. The upgrades continue to improve understanding and access to the extensive biobusiness assets distributed throughout Minnesota.
Dale Wahlstrom, BBAM CEO, recently named one of “200 Minnesotans You Should Know”
ST. LOUIS PARK, Minn. (April 8, 2010) — Dale Wahlstrom, BioBusiness Alliance of Minnesota (BBAM) CEO, was recently recognized by Twin Cities Business magazine as a “Minnesotan You Should Know.” The publication recognized 200 individuals from Minnesota to acknowledge its 200th issue.
The BioBusiness Alliance of Minnesota signs MOU with Osaka Chamber of Commerce and Industry
ST. LOUIS PARK, Minn. (March 16, 2010) — The BioBusiness Alliance of Minnesota (BBAM) recently signed a memorandum of understanding with the Osaka Chamber of Commerce and Industry (OCCI) in Japan. The goal of the MOU is to facilitate economic growth of the medical device and the biologics/biopharmaceutical industries in both Minnesota and Japan based on combined strengths in these industries.
BioBusiness Alliance of Minnesota Celebrates One Year Anniversary of Destination 2025 Release
ST. LOUIS PARK, Minn. (Jan. 28, 2010) —The BioBusiness Alliance of Minnesota (BBAM) is celebrating the anniversary of Destination 2025, a collaborative effort between BBAM and Deloitte Consulting LLP to develop a 20-year strategic plan and roadmap for Minnesota in the six life science markets in which the state participates (Medical Devices, Biologics/Biopharmaceuticals, Animal Health, Food, Renewable Energy and Renewable Materials).
ST. LOUIS PARK, Minn. (July 8, 2010)- Jeremy Lenz, BioBusiness Alliance of Minnesota (BBAM) Vice President of Operations, is joining the University Enterprise Laboratories Inc. (UEL) Board of Directors.
BioBusiness Alliance, Canadian Light Source Synchrotron Agreement Lights Way to New Life Science Research Partnerships
ST. LOUIS PARK, Minn. (May 19, 2010) - Bringing the power of synchrotron light to Minnesota’s academic and industrial life science researchers is the aim of a Memorandum of Agreement (MOA) signed today between the BioBusiness Alliance of Minnesota (BBAM) and Canada’s national synchrotron facility, the Canadian Light Source (CLS).
BioBusiness Alliance provides greater access to online resources
ST. LOUIS PARK, Minn. (April 27, 2010) – The BioBusiness Alliance of Minnesota (BBAM) unveils its new web site and upgraded BIOMAP interactive tool. The upgrades continue to improve understanding and access to the extensive biobusiness assets distributed throughout Minnesota.
Dale Wahlstrom, BBAM CEO, recently named one of “200 Minnesotans You Should Know”
ST. LOUIS PARK, Minn. (April 8, 2010) — Dale Wahlstrom, BioBusiness Alliance of Minnesota (BBAM) CEO, was recently recognized by Twin Cities Business magazine as a “Minnesotan You Should Know.” The publication recognized 200 individuals from Minnesota to acknowledge its 200th issue.
The BioBusiness Alliance of Minnesota signs MOU with Osaka Chamber of Commerce and Industry
ST. LOUIS PARK, Minn. (March 16, 2010) — The BioBusiness Alliance of Minnesota (BBAM) recently signed a memorandum of understanding with the Osaka Chamber of Commerce and Industry (OCCI) in Japan. The goal of the MOU is to facilitate economic growth of the medical device and the biologics/biopharmaceutical industries in both Minnesota and Japan based on combined strengths in these industries.
BioBusiness Alliance of Minnesota Celebrates One Year Anniversary of Destination 2025 Release
ST. LOUIS PARK, Minn. (Jan. 28, 2010) —The BioBusiness Alliance of Minnesota (BBAM) is celebrating the anniversary of Destination 2025, a collaborative effort between BBAM and Deloitte Consulting LLP to develop a 20-year strategic plan and roadmap for Minnesota in the six life science markets in which the state participates (Medical Devices, Biologics/Biopharmaceuticals, Animal Health, Food, Renewable Energy and Renewable Materials).
